tiprankstipranks
Advertisement
Advertisement
NRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
PremiumRatingsNRX Pharmaceuticals: Regulatory and Commercial De-Risking Supports Unchanged $45 Price Target and Buy Rating
8d ago
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
Premium
Company Announcements
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
9d ago
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
Premium
The Fly
Psychedelic: Enveric, NRx, Bright Minds report quarterly earnings
15d ago
Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
PremiumThe FlyPsychedelic: Jefferies initiates Compass Pathways with a Buy rating
29d ago
NRx Pharmaceuticals receives first commercial manufacturing order for ketamine
Premium
The Fly
NRx Pharmaceuticals receives first commercial manufacturing order for ketamine
1M ago
NRx Pharmaceuticals gets FDA feedback on ketamine program
Premium
The Fly
NRx Pharmaceuticals gets FDA feedback on ketamine program
1M ago
Psychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
PremiumThe FlyPsychedelic: Clearmind’s CMND-100 meets primary endpoint in trial
2M ago
NRx Pharmaceuticals announces incorporation of NRx Defense Systems
Premium
The Fly
NRx Pharmaceuticals announces incorporation of NRx Defense Systems
2M ago
NRx Pharmaceuticals appoints Glenn Tyson chief commercial officer
Premium
The Fly
NRx Pharmaceuticals appoints Glenn Tyson chief commercial officer
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100